BRIEF-Abbott agrees to DOJ settlement over 2022 infant formula recall
Reuters2026/09/14 15:57Sept 14 (Reuters) - Abbott Laboratories ABT.N:
ABBOTT REACHES AGREEMENT WITH DEPARTMENT OF JUSTICE TO RESOLVE CLAIMS RELATING TO 2022 INFANT FORMULA RECALL
ABBOTT - TO PAY $385 MILLION TO RESOLVE CLAIMS; NO FINDING OF FAULT OR LIABILITY
ABBOTT: NO UNOPENED, DISTRIBUTED ABBOTT INFANT FORMULAS HAVE EVER TESTED POSITIVE FOR CRONOBACTER SAKAZAKII
Further company coverage: ABT.N
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bank of America plunges 6%! CEO says Q3 trading revenue is flat and investment banking income falls short of expectations
Bank of America CEO Brian Moynihan stated that the bank's trading revenue this quarter will be "relatively flat" compared to the third quarter last year, in contrast to the surge in revenue experienced on Wall Street during the first half of this year. He also expects investment banking fees to be between $1.6 billion and $1.8 billion, falling short of the market's expectation of nearly $2 billion.
10-Year Treasury Yield Touches 5%, Pushed by Oil Surge-- WSJ
8 Major Banking Institutions Issue Strong Statement Against Clarity Act, the Bullish Cryptocurrency Act
Brian Moynihan Says Investment Banking Revenues Are Down at BofA -- WSJ
Crypto prices
More
